Navigation Links
Align Technology Announces Fourth Quarter and Fiscal 2008 Results
Date:1/28/2009

s First Program - (1,796) Restructuring 6,231 - Tax effect of non-GAAP adjustments (129) 43 Release of tax valuation allowance (64,608) - Non-GAAP Net profit $21,481 $33,971 Diluted Net profit per share: GAAP $1.18 $0.50 Non-GAAP $0.32 $0.48 Shares used in computing diluted net profit per share 68,064 71,444 ALIGN TECHNOLOGY, INC. BUSINESS OUTLOOK SUMMARY (unaudited) The outlook figures provided below and elsewhere in this press release are approximate in nature since Align's business outlook is difficult to predict. Align's future performance involves numerous risks and uncertainties and the company's results could differ materially from the outlook provided. Some of the factors that could affect Align's future financial performance and business outlook are set forth under "Forward Looking Information" above in this press release. Financials (in millions, except per share amounts and percentages) Q1 2009 GAAP Adjustment(a) Non-GAAP Net Revenue $65.0 - $69.0 $65.0 - $69.0 Gross Margin 72.0% - 72.5% 72.0% - 72.5% Operating Expenses $49.5 - $50.5 $1.0 (a) $48.5 - $49.5 Operating Margin (4%) - 0% 1% - 2% (2%) - 1% Net Income per Diluted Share ($0.04)- $0.00 $0.01 ($0.03)- $0.01 Stock Based Compensation Expense: Cost of Revenues $0.4
'/>"/>
SOURCE Align Technology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. MedPredict Publishes Two New Reports Providing Expert Analysis of Malignant Hematology Drug Development
2. A Stage IV Malignant Melanoma Drug That Increases Overall Survival Would Earn a Higher Patient Share in the U.S. Than in Europe
3. Tennessee Hospital Association Selects PivotHealth To Provide Hospital-Physician Alignment Services
4. FDA Clears Expanded Labeling for the Invisalign System
5. Align Technology to Announce Fourth Quarter and Fiscal Year 2008 Results on January 28, 2009
6. Cardo Medical Announces FDA Clearance of the Align 360 Total Knee System
7. Align Technology Announces Third Quarter Fiscal 2008 Results
8. 5- and 10-year survival continues to improve for US children with hematologic malignancies
9. SpectraScience Awarded Patent for Correcting Image Misalignment
10. Align Technology Announces Second Quarter Fiscal 2008 Results
11. Align Technology Targets Mainstream Orthodontics Market With Invisalign Teen(TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)....25/PRNewswire-USNewswire/--TheBlackAIDSInstituter...utiveleadershipfor2010. ,, ThenewBoardMembersar...icpolicy,law,finance,governmenthealthprograms,edit...sfromawiderangeofpersonalbackgroundsincludingbothh...Vthemselves,andrepresentingmultipleagegroups. ,...
(Date:11/25/2009)...nd evidence of a statistically significant surviva...hose estrogen receptor (ER)-positive tumors had hi...e-118 (ER-alpha S118-P), according to a brief comm...rnal of the National Cancer Institute . , Approx...tamoxifen. Preclinical studies have shown that ER-...
(Date:11/25/2009)...d to fight rheumatoid arthritis, could help newly ...NESDAY, Nov. 25 (HealthDay News) -- A drug commonl...oid arthritis now also shows some promise in helpi..., The drug, rituximab (Rituxan), helped patient...hough the disease had destroyed some of their panc...
(Date:11/25/2009)... CDC sees few signs of trouble with the H1N1 vacci...ews) -- The ongoing H1N1 swine flu pandemic may be...ong younger patients, a U.S. health official said ...ous pneumococcal infections around the country," D...for Immunization and Respiratory Diseases at the U...
(Date:11/25/2009)...A cancer vaccine carried into the body on a carefu...rst to successfully eliminate tumors in mammals, s... Translational Medicine . , The new approach, pi...rd University, uses plastic disks impregnated with...kin to reprogram the mammalian immune system to at...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
... a matter of debate, experts say , , MONDA...e premiums increase, so do the rates of Caesarean ... a small snapshot of the association, drawing on d...ther higher malpractice rates boost the C-section ...
...Care are Key Issues Facing State, SACRAMENTO, Cal...onday will host the latest in a series of statewid...ss the crisis facing the,state,s healthcare infras...sparities in quality of care,delivered at differen...
...ogix, Inc. (Nasdaq:,IFLG), a leading technology pr...althcare and commercial industries, announced toda... at the AeA Micro Cap Financial,Conference. The Co...l Conference can be found at:, http://www.aeanet.o...
... landmark study shows,dangerous dioxins are passed...can be significantly reduced by Chlorella pyrenoid...cinal Food, analyzed dioxin,levels in breast milk ...er in the breast milk of the women taking Chlorell...
...hen detected early, most skin,cancers can be succe...us,form of skin cancer, is highly curable when fou...for people whose melanoma is detected and treated,...ent by individuals to perform regular skin self-ex...
...pational exposure to sunlight less likely to be ... worker, SCHAUMBURG, Ill., May 5 While occupatio...ake a living toiling in the sun face an,increased ...the most by nature of their occupation -- such as,...
Other Medicine News:Health News:Malpractice Premiums, Rate of C-Sections Rise Together 2Health News:Malpractice Premiums, Rate of C-Sections Rise Together 3Health News:MEDIA ADVISORY: InfoLogix to Present at AeA Micro Cap Conference in Monterey California 2Health News:New Studies Support Dermatologists' Recommendation: Self-Exams, Screenings Vital for Detecting Skin Cancer 2Health News:New Studies Support Dermatologists' Recommendation: Self-Exams, Screenings Vital for Detecting Skin Cancer 3Health News:New Studies Support Dermatologists' Recommendation: Self-Exams, Screenings Vital for Detecting Skin Cancer 4Health News:New Studies Support Dermatologists' Recommendation: Self-Exams, Screenings Vital for Detecting Skin Cancer 5Health News:Warning: New Skin Cancer Study Finds Outdoor Workers are Less Likely to Get Screened for Skin Cancer 2Health News:Warning: New Skin Cancer Study Finds Outdoor Workers are Less Likely to Get Screened for Skin Cancer 3Health News:Warning: New Skin Cancer Study Finds Outdoor Workers are Less Likely to Get Screened for Skin Cancer 4
(Date:11/25/2009)...e/--AccordingtoMillenniumResearchGroup(MRG),theglo...thenearly$3billionUSmarketfortraumafixationdevices...spitetherecenteconomicslowdown.MRG,s USMarketsforT...mainhighlydynamicoverthenextfiveyears,withcompetit...ervedsegmentsofthetraumafixationmarket,fuelingmark...
(Date:11/25/2009)...SBURG,November25/PRNewswire/--,iThembaPharmaceutic...,thattheyhavesignedacollaborativeagreementtojointl...dclasscomputationalchemistryandleaddiscoveryexpert...videmedicinaland,syntheticchemistrysupporttoprojec...rk.iThembaPharmaceuticalsandPyxisDiscovery,alsoann...
(Date:11/24/2009)...e-FirstCall/--Endologix,Inc.(Nasdaq: ELGX ),develo...,announcedtodaythatithasfiledamotiontostay,ordisco...tbroughtagainstitinOctober2009byCook,Inc.Themotion...is,Indiana. ,, Endologixhasrequestedthatthestay...rkOffice(USPTO)conductsproceedingstore-examinethet...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts 53902 1Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts 53902 2Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts 53902 3Chindex International Inc Launches World Class Cancer Treatment Center 53897 1Chindex International Inc Launches World Class Cancer Treatment Center 53897 2Chindex International Inc Launches World Class Cancer Treatment Center 53897 3Chindex International Inc Launches World Class Cancer Treatment Center 53897 4IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 1IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 2IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 3IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 4IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 5IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 6IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 7IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 8IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 9IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 10IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 11IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 12IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 13IPC The Hospitalist Company Reports Second Quarter 2009 Results 53892 14
...ht Favorable Tolerability and,Additive Antiviral A...PRNewswire-FirstCall/ -- ViroPharma,Incorporated t...dy,of HCV- 796, a unique, orally dosed hepatitis C...al Meeting of the European,Association for the Stu... in Barcelona, Spain. These data on the antiviral,...
...PRNewswire/ -- Cequent,Pharmaceuticals, a pioneer ...Ai-based treatments to prevent and treat human dis...ill present a,scientific poster on Cequent,s propr...technology at the 2007 annual meeting of,the Ameri...ntor,Johannes Fruehauf, MD, PhD, of Beth Israel D...
Other Medicine Technology:ViroPharma Announces Presentation of Additional HCV-796 Data at,Meeting of The European Association for the Study of the Liver 2ViroPharma Announces Presentation of Additional HCV-796 Data at,Meeting of The European Association for the Study of the Liver 3ViroPharma Announces Presentation of Additional HCV-796 Data at,Meeting of The European Association for the Study of the Liver 4ViroPharma Announces Presentation of Additional HCV-796 Data at,Meeting of The European Association for the Study of the Liver 5ViroPharma Announces Presentation of Additional HCV-796 Data at,Meeting of The European Association for the Study of the Liver 6Cequent Pharmaceuticals Founder to Present tkRNAi Technology at the,American Association of Cancer Research Annual Meeting in Los,Angeles 2Cequent Pharmaceuticals Founder to Present tkRNAi Technology at the,American Association of Cancer Research Annual Meeting in Los,Angeles 3
New Image Cut-to-Fit Flextend Skin Barrier, Floating Flange, with Tape
New Image Cut-to-Fit Convex Flextend Skin Barrier
CenterPointLock Urostomy Pouch, Beige
CenterPointLock Sterile Ostomy/Wound Care Kit
Medicine Products: